This Is MS Multiple Sclerosis Community: Knowledge & Support

Tysabri-associated PML in MS: better survival rates than other patient types



A follow-up study of 35 MS patients with Tysabri-associated progressive multifocal leukoencephalopathy provides a somewhat encouraging survival rate of about 70%.

This percentage is more than twice the quoted survival rate of other patient types with PML (eg, those with HIV infection or following transplantation), and the authors speculate that the improved survival in Tysabri-related cases may be due (partially) to the ability to reconstitute the immune system more easily in these cases.

Factors that appear ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis

Is this for good or for bad? Am I the only one who wouldn't want to survive after getting PML?

_________________
Shortest joke: "We may not be able to cure MS but we can manage its symptoms."

I'm with you, sou.

_________________
Dx'd with MS & HNPP (hereditary peripheral neuropathy) 7/03 but must have had MS for 30 yrs before that. I've never taken meds for MS or MS symptoms except 1 yr experiment on LDN. (I found diet, exercise, sleep, humor, music help me the most.)

The study was done to try and improve the marketing/sales of Tysabri. Ever since the drug was first approved, Biogen has continually tried to minimize the danger of PML. After all, PML risk is bad for sales and with the orals starting to appear. the competition noose is tightening.

Harry